Tuning Selectivity of Dendron Micelles through Variations of the PEG Corona

June 6, 2016

Abstract

Engineering controllable cellular interactions into nanoscale drug delivery systems is key to enable their full potential. Here, using folic acid (FA) as a model targeting ligand and dendron micelles (DM) as a nanoparticle (NP) platform, we present a comprehensive experimental and modeling investigation of the structural properties of DMs that govern the formation of controllable, FA-mediated cellular interactions. Our experimental results demonstrate that a high level of control over the specific cell interactions of FA-targeted DMs can be achieved through modulation of the PEG corona length and the FA content. Using various molecular weight PEGs (0.6K, 1K, and 2K g/mol) and contents of dendron-FA conjugate incorporated into DMs (0, 5, 10, 25 wt %), the cell interactions of the targeted DMs could be controlled to exhibit minimal to >25-fold enhancement over nontargeted DMs. Molecular dynamics simulations indicated that structural characteristics, such as solvent accessible surface area of FA, local PEG density near FA, and FA mobility, account in part for the experimental differences in cellular interactions. The molecular structure that allows FA to depart from the surface of DMs to facilitate the initial cell surface binding was revealed to be the most important contributor for determining FA-mediated cellular interactions of DMs. The modular properties of DMs in controlling their specific cell interactions support the potential of DMs as a delivery platform and offer design cues for future development of targeted NPs.

Published

ACS Nano journal cover Vol. 10 No. 7

Cited by

This article is cited by 13 publications

  1. Dodd-O, J., Roy, A., Siddiqui, Z., Jafari, R., Coppola, F., Ramasamy, S., Kolloli, A., Kumar, D., Kaundal, S., Zhao, B., Kumar, R., Robang, A. S., Li, J., Azizogli, A. R., Pai, V., Acevedo-Jake, A., Heffernan, C., Lucas, A., McShan, A. C., Paravastu, A. K., … Kumar, V. (2024). Antiviral fibrils of self-assembled peptides with tunable compositions. Nature communications, 15(1), 1142. https://doi.org/10.1038/s41467-024-45193-3
  2. Rawding, P. A., Bu, J., Wang, J., Kim, D. W., Drelich, A. J., Kim, Y., & Hong, S. (2022). Dendrimers for cancer immunotherapy: Avidity-based drug delivery vehicles for effective anti-tumor immune response. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 14(2), e1752. https://doi.org/10.1002/wnan.1752
  3. Jeong, W. J., Bu, J., Jafari, R., Rehak, P., Kubiatowicz, L. J., Drelich, A. J., Owen, R. H., Nair, A., Rawding, P. A., Poellmann, M. J., Hopkins, C. M., Král, P., & Hong, S. (2022). Hierarchically Multivalent Peptide-Nanoparticle Architectures: A Systematic Approach to Engineer Surface Adhesion. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 9(4), e2103098. https://doi.org/10.1002/advs.202103098
  4. Skibba, M., Drelich, A., Poellmann, M., Hong, S., & Brasier, A. R. (2020). Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis. Frontiers in pharmacology, 11, 607689. https://doi.org/10.3389/fphar.2020.607689
  5. Chakraborty, A., Lasola, J., Truong, N., & Pearson, R. M. (2020). Serum-Independent Nonviral Gene Delivery to Innate and Adaptive Immune Cells Using Immunoplexes. ACS applied bio materials, 3(9), 6263–6272. https://doi.org/10.1021/acsabm.0c00761